CAS 2050478-92-5

Cetrelimab

CAS : 2050478-92-5

Cetrelimab (JNJ 63723283) is a humanized monoclonal antibody targeting PD-1, useful in research on multiple myeloma and bladder cancer.

Degré de pureté : >95%

Couleur et forme : Liquid

Masse moléculaire : 145.04 kDa

Ref: TM-T76945

Cetrelimab

CAS : 2050478-92-5

An anti-human IgG4 kappa, anti-programmed cell death protein-1 (PD-1) antibody.

Ref: 3D-CLA1518